Browne M K
Pharmatherapeutica. 1981;2(8):517-22.
An open study was carried out on patients with acute appendicitis to assess the effectiveness of taurolin, a new antiseptic which destroys both bacteria and endotoxin, when used intraperitoneally in cases of purulent peritonitis associated with perforated or gangrenous appendicitis. Seventy-four out of 319 patients received taurolin; the others were treated by operation only or by operation and antibiotics as required. The results suggest that taurolin was effective as monotherapy in peritonitis and endotoxic shock and its use avoids the problems associated with antibiotics.
对急性阑尾炎患者进行了一项开放性研究,以评估新型防腐剂牛磺罗宁在与穿孔性或坏疽性阑尾炎相关的化脓性腹膜炎病例中腹腔内使用时破坏细菌和内毒素的有效性。319名患者中有74名接受了牛磺罗宁治疗;其他患者仅接受手术治疗或根据需要接受手术和抗生素治疗。结果表明,牛磺罗宁作为腹膜炎和内毒素休克的单一疗法有效,并且其使用避免了与抗生素相关的问题。